250 related articles for article (PubMed ID: 10516612)
1. Use of mean platelet component to measure platelet activation on the ADVIA 120 haematology system.
Macey MG; Carty E; Webb L; Chapman ES; Zelmanovic D; Okrongly D; Rampton DS; Newland AC
Cytometry; 1999 Oct; 38(5):250-5. PubMed ID: 10516612
[TBL] [Abstract][Full Text] [Related]
2. Comparison of platelet activation in platelet concentrates measured by flow cytometry or ADVIA 2120.
Beard MJ; Jeewa Z; Bashir S; Cardigan R; Thomas S
Vox Sang; 2011 Aug; 101(2):122-30. PubMed ID: 21492182
[TBL] [Abstract][Full Text] [Related]
3. Assessment of platelet activation in several different anticoagulants by the Advia 120 Hematology System, fluorescence flow cytometry, and electron microscopy.
Ahnadi CE; Sabrinah Chapman E; Lépine M; Okrongly D; Pujol-Moix N; Hernández A; Boughrassa F; Grant AM
Thromb Haemost; 2003 Nov; 90(5):940-8. PubMed ID: 14597991
[TBL] [Abstract][Full Text] [Related]
4. Preanalytical treatment of EDTA-anticoagulated blood to ensure stabilization of the mean platelet volume and component measured with the ADVIA counters.
Diaz-Ricart M; Brunso L; Pino M; Navalon F; Jou JM; Heras M; White JG; Escolar G
Thromb Res; 2010 Jul; 126(1):e30-5. PubMed ID: 20427079
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system.
Macey M; Azam U; McCarthy D; Webb L; Chapman ES; Okrongly D; Zelmanovic D; Newland A
Clin Chem; 2002 Jun; 48(6 Pt 1):891-9. PubMed ID: 12029005
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous assay of activated platelet count and platelet-activating capacity by P-selectin detection using K2-EDTA-treated whole blood for antiplatelet agents.
Okano K; Araki M; Mimura Y; Nogaki H; Ichihara K
Int J Lab Hematol; 2012 Dec; 34(6):621-9. PubMed ID: 22862794
[TBL] [Abstract][Full Text] [Related]
7. Ethylenediaminetetraacetic acid plus citrate-theophylline-adenosine-dipyridamole (EDTA-CTAD): a novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole blood.
Macey M; McCarthy D; Azam U; Milne T; Golledge P; Newland A
Cytometry B Clin Cytom; 2003 Jan; 51(1):30-40. PubMed ID: 12500295
[TBL] [Abstract][Full Text] [Related]
8. A rapid, automated flow cytometric method to measure activated degranulated platelets by density determination.
Chapman ES; Sorette M; Hetherington E; Zelmanovic D; Kling G; Dugailliez J; Pujol-Moix N; Okrongly D
Thromb Haemost; 2003 Jun; 89(6):1004-15. PubMed ID: 12783113
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two methods to assess variability of platelet response to anti-platelet therapies in patients with acute coronary syndrome undergoing angioplasty.
Ahnadi CE; Boughrassa FF; Chapman-Montgomery ES; Poisson V; Gervais A; Okrongly D; Grant AM
Thromb Haemost; 2004 Dec; 92(6):1207-13. PubMed ID: 15583725
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two platelet activation markers using flow cytometry after in vitro shear stress exposure of whole human blood.
Lu Q; Malinauskas RA
Artif Organs; 2011 Feb; 35(2):137-44. PubMed ID: 20946295
[TBL] [Abstract][Full Text] [Related]
11. Whole blood microvolume laser scanning cytometry for monitoring resting and activated platelets.
Wyant TL; Smith PC; Brown B; Kantor AB
Platelets; 2001 Aug; 12(5):309-18. PubMed ID: 11487384
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of delta value of platelet parameters on ADVIA 120 for the functional reactivity of stored platelets.
Park IJ; Lim YA; Cho SR
J Clin Lab Anal; 2010; 24(1):38-43. PubMed ID: 20087952
[TBL] [Abstract][Full Text] [Related]
13. Can mean platelet component be used as an index of platelet activity in stable coronary artery disease?
Cooke J; Murphy T; McFadden E; O'Reilly M; Cahill MR
Hematology; 2009 Apr; 14(2):111-4. PubMed ID: 19298724
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of platelets, platelet microparticles, and platelet aggregates with flow cytometry.
Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H
J Lab Clin Med; 1998 Jun; 131(6):507-17. PubMed ID: 9626986
[TBL] [Abstract][Full Text] [Related]
15. A comparison of platelet parameters in EDTA- and citrate-anticoagulated blood in dogs.
Stokol T; Erb HN
Vet Clin Pathol; 2007 Jun; 36(2):148-54. PubMed ID: 17523088
[TBL] [Abstract][Full Text] [Related]
16. Relative and absolute changes of activated platelets, microparticles and platelet aggregates after activation in vitro.
Matzdorff AC; Berchner D; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R
Haemostasis; 1998; 28(6):277-88. PubMed ID: 10461010
[TBL] [Abstract][Full Text] [Related]
17. Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activation.
Ito H; Miyakoda G; Mori T
Platelets; 2004 Aug; 15(5):293-301. PubMed ID: 15370100
[TBL] [Abstract][Full Text] [Related]
18. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
[TBL] [Abstract][Full Text] [Related]
19. Preanalytical requirements for flow cytometric evaluation of platelet activation: choice of anticoagulant.
Mody M; Lazarus AH; Semple JW; Freedman J
Transfus Med; 1999 Jun; 9(2):147-54. PubMed ID: 10354385
[TBL] [Abstract][Full Text] [Related]
20. The value of flow cytometry in the measurement of platelet activation and aggregation in human immunodeficiency virus infection.
Nkambule BB; Davison G; Ipp H
Platelets; 2015; 26(3):250-7. PubMed ID: 24831969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
